Vascular Dementia and Crosstalk Between the Complement and Coagulation Systems.

Milad Mossanen Parsi, C��dric Duval, Robert A S Ari��ns
Author Information
  1. Milad Mossanen Parsi: Discovery and Translational Science Department, School of Medicine, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.
  2. C��dric Duval: Discovery and Translational Science Department, School of Medicine, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.
  3. Robert A S Ari��ns: Discovery and Translational Science Department, School of Medicine, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.

Abstract

Vascular Dementia (VaD) is a neurocognitive disorder caused by reduced blood flow to the brain tissue, resulting in infarction, and is the second most common type of dementia. The complement and coagulation systems are evolutionary host defence mechanisms activated by acute tissue injury to induce inflammation, clot formation and lysis; recent studies have revealed that these systems are closely interlinked. Overactivation of these systems has been recognised to play a key role in the pathogenesis of neurological disorders such as Alzheimer's disease and multiple sclerosis, however their role in VaD has not yet been extensively reviewed. This review aims to bridge the gap in knowledge by collating current understanding of VaD to enable identification of complement and coagulation components involved in the pathogenesis of this disorder that may have their effects amplified or supressed by crosstalk. Exploration of these mechanisms may unveil novel therapeutic targets or biomarkers that would improve current treatment strategies for VaD.

Keywords

References

  1. Thromb Haemost. 1997 Feb;77(2):394-8 [PMID: 9157602]
  2. Diabetes. 2009 Jan;58(1):71-7 [PMID: 18952836]
  3. Stroke. 2004 Aug;35(8):1810-5 [PMID: 15232128]
  4. Free Radic Biol Med. 2006 Jun 1;40(11):1903-13 [PMID: 16716892]
  5. J Biol Chem. 1998 Feb 20;273(8):4378-86 [PMID: 9468488]
  6. Funct Neurol. 2012 Jan-Mar;27(1):35-40 [PMID: 22687165]
  7. Prog Biophys Mol Biol. 2008 Jan-Apr;96(1-3):499-509 [PMID: 17854869]
  8. Ther Adv Neurol Disord. 2009 Jul;2(4):241-60 [PMID: 21179532]
  9. J Exp Med. 1983 Aug 1;158(2):603-15 [PMID: 6604123]
  10. Mol Immunol. 2015 Sep;67(1):108-18 [PMID: 25886718]
  11. Blood. 2005 Apr 1;105(7):2777-82 [PMID: 15598816]
  12. Blood. 2002 Jul 15;100(2):517-23 [PMID: 12091343]
  13. Lancet Neurol. 2015 Sep;14(9):903-913 [PMID: 26227434]
  14. Blood. 2017 Apr 20;129(16):2291-2302 [PMID: 28223279]
  15. Neuropharmacology. 2018 May 15;134(Pt B):226-239 [PMID: 29273521]
  16. Stroke. 2016 Nov;47(11):2722-2728 [PMID: 27703087]
  17. QJM. 2010 Jan;103(1):17-21 [PMID: 19843602]
  18. Lancet Neurol. 2009 Jul;8(7):643-53 [PMID: 19539236]
  19. Neurobiol Aging. 2009 Mar;30(3):337-52 [PMID: 17869382]
  20. Neurology. 2012 Apr 3;78(14):1043-50 [PMID: 22377814]
  21. Diab Vasc Dis Res. 2010 Oct;7(4):260-73 [PMID: 20847109]
  22. Stroke. 2010 Aug;41(8):1579-86 [PMID: 20595675]
  23. Neurobiol Aging. 2007 Dec;28(12):1810-20 [PMID: 17011077]
  24. Neuroepidemiology. 2014;42(4):243-51 [PMID: 24862944]
  25. Blood. 2014 May 8;123(19):2934-43 [PMID: 24620349]
  26. J Immunol. 2010 Nov 1;185(9):5628-36 [PMID: 20870944]
  27. J Mol Med (Berl). 2012 Feb;90(2):119-26 [PMID: 21909687]
  28. Am J Epidemiol. 1988 Jul;128(1):116-23 [PMID: 3381820]
  29. Atherosclerosis. 2014 Aug;235(2):384-91 [PMID: 24929287]
  30. Blood. 2019 Feb 28;133(9):906-918 [PMID: 30642917]
  31. Blood. 1986 Oct;68(4):875-80 [PMID: 3092889]
  32. Cardiovasc Res. 1997 May;34(2):255-65 [PMID: 9205537]
  33. J Exp Med. 2005 Mar 21;201(6):871-9 [PMID: 15781579]
  34. Nat Med. 2004 Jul;10 Suppl:S18-25 [PMID: 15298006]
  35. Neurology. 1995 Aug;45(8):1483-7 [PMID: 7644045]
  36. BMJ. 1996 Mar 30;312(7034):805-8 [PMID: 8608286]
  37. Neurology. 2008 Apr 1;70(14):1208-14 [PMID: 18378884]
  38. Diabetes Care. 2009 Jan;32(1):169-74 [PMID: 18945929]
  39. Transfus Med Rev. 2019 Oct;33(4):199-206 [PMID: 31672340]
  40. Eur J Neurol. 2020 Aug;27(8):1588-1595 [PMID: 32348626]
  41. Biochem Soc Trans. 2014 Aug;42(4):1001-5 [PMID: 25109993]
  42. Brain. 2003 Feb;126(Pt 2):424-32 [PMID: 12538408]
  43. Stroke. 1997 Nov;28(11):2222-9 [PMID: 9368569]
  44. Brain. 2004 Oct;127(Pt 10):2265-75 [PMID: 15282216]
  45. Neurology. 2013 Jul 16;81(3):264-72 [PMID: 23858408]
  46. Dement Geriatr Cogn Disord. 2004;18(3-4):265-70 [PMID: 15286458]
  47. J Neurol Neurosurg Psychiatry. 2011 May;82(5):527-33 [PMID: 20974649]
  48. Acta Neuropathol. 2010 May;119(5):579-89 [PMID: 20091409]
  49. J Neuropathol Exp Neurol. 2000 Nov;59(11):931-45 [PMID: 11089571]
  50. J Neurol Sci. 2010 Dec 15;299(1-2):131-5 [PMID: 20850134]
  51. J Cereb Blood Flow Metab. 2012 Jul;32(7):1207-21 [PMID: 22395208]
  52. Lancet Neurol. 2013 May;12(5):483-97 [PMID: 23602162]
  53. Semin Immunopathol. 2012 Jan;34(1):151-65 [PMID: 21811895]
  54. Arch Neurol. 2006 May;63(5):686-92 [PMID: 16533956]
  55. Stroke. 2009 Jan;40(1):285-93 [PMID: 18988906]
  56. Adv Immunol. 1997;66:225-72 [PMID: 9328643]
  57. Lancet Neurol. 2009 Nov;8(11):1006-18 [PMID: 19782001]
  58. J Cereb Blood Flow Metab. 2010 Apr;30(4):837-48 [PMID: 19997118]
  59. Br J Haematol. 2018 Mar;180(6):782-798 [PMID: 29265338]
  60. Blood. 2013 Mar 21;121(12):2324-35 [PMID: 23315166]
  61. Neurology. 2019 Jan 15;92(3):e253-e262 [PMID: 30568001]
  62. Haemostasis. 1998 May-Aug;28(3-4):216-22 [PMID: 10420069]
  63. Neurobiol Aging. 2000 Mar-Apr;21(2):331-42 [PMID: 10867218]
  64. Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):461-3 [PMID: 20167665]
  65. J Stroke Cerebrovasc Dis. 2017 Apr;26(4):823-833 [PMID: 27876311]
  66. Mol Immunol. 2010 Aug;47(13):2161-9 [PMID: 20580091]
  67. Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):599-604 [PMID: 19965782]
  68. Neurobiol Aging. 2001 May-Jun;22(3):407-12 [PMID: 11378246]
  69. Neuropathol Appl Neurobiol. 2017 Aug;43(5):409-418 [PMID: 27664944]
  70. Arch Intern Med. 2002 Oct 14;162(18):2090-6 [PMID: 12374517]
  71. J Thromb Haemost. 2011 Aug;9(8):1475-82 [PMID: 21676170]
  72. Cell Res. 2010 Jan;20(1):34-50 [PMID: 20010915]
  73. BMC Med. 2016 May 20;14:77 [PMID: 27197724]
  74. Stroke. 2010 Feb;41(2):218-23 [PMID: 20035077]
  75. Int J Clin Pract. 2005 Jan;59(1):52-7 [PMID: 15707465]
  76. Stroke. 2012 Nov;43(11):3137-46 [PMID: 22935401]
  77. Lancet Neurol. 2003 Apr;2(4):238-45 [PMID: 12849212]
  78. J Neurol Neurosurg Psychiatry. 2008 Dec;79(12):1344-8 [PMID: 18586864]
  79. Lancet Neurol. 2007 Jul;6(7):611-9 [PMID: 17582361]
  80. J Immunol. 2005 May 15;174(10):6373-80 [PMID: 15879138]
  81. Stroke. 2011 Feb;42(2):445-52 [PMID: 21193743]
  82. Pharmacol Rev. 2005 Mar;57(1):27-77 [PMID: 15734727]
  83. Blood. 2011 Aug 18;118(7):2007-14 [PMID: 21705496]
  84. J Am Geriatr Soc. 2007 May;55(5):700-7 [PMID: 17493189]
  85. PLoS One. 2011;6(6):e21338 [PMID: 21712986]
  86. Sci Signal. 2014 Jan 07;7(307):ra1 [PMID: 24399295]
  87. Int J Mol Sci. 2020 Feb 07;21(3): [PMID: 32046035]
  88. Exp Neurol. 2015 Oct;272:97-108 [PMID: 25987538]
  89. Neuropathol Appl Neurobiol. 2018 Apr;44(3):247-266 [PMID: 29380913]
  90. Stroke. 2001 Dec 1;32(12):2735-40 [PMID: 11739965]
  91. Curr Atheroscler Rep. 2018 Jul 5;20(9):43 [PMID: 29974259]
  92. Acta Neuropathol. 2016 May;131(5):659-85 [PMID: 27062261]
  93. Mol Immunol. 2010 Aug;47(13):2170-5 [PMID: 20621693]
  94. Brain Pathol. 2012 Sep;22(5):583-91 [PMID: 22329603]
  95. Clin Exp Immunol. 2018 Oct;194(1):103-117 [PMID: 30260475]
  96. Front Immunol. 2020 Oct 27;11:548604 [PMID: 33193314]
  97. J Clin Invest. 2000 Mar;105(5):597-605 [PMID: 10712431]
  98. Eur J Immunol. 2015 Feb;45(2):544-50 [PMID: 25359215]
  99. Neurology. 2019 Jan 16;: [PMID: 30651383]
  100. Int J Neurosci. 2012 Sep;122(9):494-9 [PMID: 22519891]
  101. BMC Neurol. 2008 Mar 27;8:5 [PMID: 18371212]
  102. Stroke. 2000 Oct;31(10):2385-9 [PMID: 11022068]
  103. Neurology. 1999 Dec 10;53(9):1937-42 [PMID: 10599761]
  104. J Biol Chem. 1990 Mar 5;265(7):3809-14 [PMID: 2105954]
  105. Curr Neuropharmacol. 2018;16(7):1036-1044 [PMID: 29046153]
  106. Stroke. 2011 May;42(5):1345-50 [PMID: 21454822]
  107. Ther Adv Cardiovasc Dis. 2017 Aug;11(8):215-225 [PMID: 28639538]
  108. Neurobiol Aging. 2011 Nov;32(11):1932-41 [PMID: 20045217]
  109. Lancet Neurol. 2010 Jul;9(7):689-701 [PMID: 20610345]
  110. Front Cardiovasc Med. 2019 Sep 06;6:131 [PMID: 31555668]
  111. Stroke. 2010 Jun;41(6):1213-21 [PMID: 20395618]
  112. N Engl J Med. 2011 Aug 11;365(6):537-47 [PMID: 21830968]
  113. Alzheimers Dement. 2009 Nov;5(6):454-62 [PMID: 19896584]
  114. Arterioscler Thromb Vasc Biol. 2019 Aug;39(8):1542-1549 [PMID: 31294622]
  115. Ann Epidemiol. 1992 Jul;2(4):509-19 [PMID: 1342301]
  116. Nature. 1989 Apr 6;338(6215):518-20 [PMID: 2927510]
  117. PLoS One. 2020 Nov 16;15(11):e0242062 [PMID: 33196677]
  118. Brain. 2016 Nov 1;139(11):2957-2969 [PMID: 27591113]
  119. Stroke. 1999 Dec;30(12):2513-6 [PMID: 10582970]
  120. Clin Appl Thromb Hemost. 2014 Mar;20(2):124-8 [PMID: 23677913]
  121. Neurobiol Aging. 2010 Oct;31(10):1710-20 [PMID: 18996621]
  122. Postgrad Med J. 2006 Jun;82(968):357-62 [PMID: 16754702]
  123. Thromb Res. 2016 Sep;145:84-92 [PMID: 27513882]
  124. Stroke. 2003 Aug;34(8):2050-9 [PMID: 12829866]
  125. Ann Neurol. 2015 May;77(5):784-803 [PMID: 25628066]
  126. Brain Pathol. 2000 Jan;10(1):113-26 [PMID: 10668901]
  127. Neural Plast. 2019 Nov 14;2019:1071036 [PMID: 31814819]
  128. Theranostics. 2020 Jan 1;10(1):74-90 [PMID: 31903107]
  129. Prog Neurobiol. 2013 Feb-Mar;101-102:65-82 [PMID: 23274649]
  130. Stroke. 2007 Jun;38(6):1949-51 [PMID: 17510457]
  131. J Cereb Blood Flow Metab. 2004 Mar;24(3):334-42 [PMID: 15091114]
  132. Proc Natl Acad Sci U S A. 2011 May 3;108(18):7523-8 [PMID: 21502512]
  133. Am J Epidemiol. 1987 Dec;126(6):1103-14 [PMID: 3687920]
  134. J Thromb Haemost. 2006 Sep;4(9):2035-42 [PMID: 16961611]
  135. Brain Pathol. 2014 Sep;24(5):525-44 [PMID: 25323668]
  136. Antioxid Redox Signal. 2015 Jan 10;22(2):149-60 [PMID: 24328757]
  137. N Engl J Med. 2016 Feb 11;374(6):523-32 [PMID: 26863354]
  138. Cerebrovasc Dis. 2012;33(1):69-75 [PMID: 22133999]
  139. Semin Thromb Hemost. 2019 Jul;45(5):514-522 [PMID: 31096308]
  140. Stroke. 2005 Dec;36(12):2637-41 [PMID: 16269641]
  141. Diabetologia. 2008 Feb;51(2):241-8 [PMID: 18060658]
  142. J Neurosci. 2002 Jan 15;22(2):455-63 [PMID: 11784790]
  143. J Neurol Sci. 2010 Dec 15;299(1-2):136-8 [PMID: 20920816]
  144. N Engl J Med. 2009 Apr 23;360(17):1729-39 [PMID: 19387015]
  145. Hypertension. 2013 Jun;61(6):1354-9 [PMID: 23529163]
  146. Alzheimers Dement. 2018 Nov;14(11):1416-1426 [PMID: 30177276]
  147. Nat Med. 2006 Jun;12(6):682-7 [PMID: 16715088]
  148. Am J Pathol. 2000 May;156(5):1549-56 [PMID: 10793066]
  149. Neurology. 2012 May 8;78(19):1456-63 [PMID: 22551732]
  150. Stroke. 1996 Jan;27(1):30-6 [PMID: 8553399]
  151. Thromb Haemost. 2014 Jun;111(6):1102-11 [PMID: 24500020]

Grants

  1. /Wellcome Trust
  2. 204951/Z/16/Z/Wellcome Trust
  3. RG/13/3/30104/British Heart Foundation
  4. RG/18/11/34036/British Heart Foundation

Word Cloud

Created with Highcharts 10.0.0VaDcomplementcoagulationsystemsVascularDementiadisordertissuedementiamechanismsrolepathogenesisdiseasecurrentmaycrosstalkneurocognitivecausedreducedbloodflowbrainresultinginfarctionsecondcommontypeevolutionaryhostdefenceactivatedacuteinjuryinduceinflammationclotformationlysisrecentstudiesrevealedcloselyinterlinkedOveractivationrecognisedplaykeyneurologicaldisordersAlzheimer'smultiplesclerosishoweveryetextensivelyreviewedreviewaimsbridgegapknowledgecollatingunderstandingenableidentificationcomponentsinvolvedeffectsamplifiedsupressedExplorationunveilnoveltherapeutictargetsbiomarkersimprovetreatmentstrategiesCrosstalkComplementCoagulationSystemssmallvesselvascular

Similar Articles

Cited By (8)